Quantitative risk assessment of COVID-19 and serious illness among spectators at mass gathering events with vaccine-testing package implementation
View ORCID ProfileMichio Murakami, Tsukasa Fujita, Yuichi Iwasaki, Masaki Onishi, Wataru Naito, Seiya Imoto, Tetsuo Yasutaka
doi: https://doi.org/10.1101/2022.01.30.22269980
Michio Murakami
aCenter for Infectious Disease Education and Research (CiDER), Osaka University, 2-8 Yamadaoka, Suita, Osaka 565-0871, Japan
bInstitute for Geo-Resources and Environment, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1, Higashi, Tsukuba, Ibaraki, 305-8567, Japan
Tsukasa Fujita
bInstitute for Geo-Resources and Environment, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1, Higashi, Tsukuba, Ibaraki, 305-8567, Japan
Yuichi Iwasaki
cResearch Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST), 16-1, Onogawa, Tsukuba, Ibaraki, 305-8569, Japan
Masaki Onishi
dArtificial Intelligence Research Center, National Institute of Advanced Industrial Science and Technology (AIST), 2-4-7 Aomi, Koto-ku, Tokyo, 135-0064, Japan
Wataru Naito
cResearch Institute of Science for Safety and Sustainability, National Institute of Advanced Industrial Science and Technology (AIST), 16-1, Onogawa, Tsukuba, Ibaraki, 305-8569, Japan
Seiya Imoto
eDivision of Health Medical Intelligence, Human Genome Center, The Institute of Medical Science, The University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo, 108-8639, Japan
Tetsuo Yasutaka
bInstitute for Geo-Resources and Environment, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1, Higashi, Tsukuba, Ibaraki, 305-8567, Japan

Data Availability
All data produced in the present work are contained in the manuscript.
Posted January 31, 2022.
Quantitative risk assessment of COVID-19 and serious illness among spectators at mass gathering events with vaccine-testing package implementation
Michio Murakami, Tsukasa Fujita, Yuichi Iwasaki, Masaki Onishi, Wataru Naito, Seiya Imoto, Tetsuo Yasutaka
medRxiv 2022.01.30.22269980; doi: https://doi.org/10.1101/2022.01.30.22269980
Quantitative risk assessment of COVID-19 and serious illness among spectators at mass gathering events with vaccine-testing package implementation
Michio Murakami, Tsukasa Fujita, Yuichi Iwasaki, Masaki Onishi, Wataru Naito, Seiya Imoto, Tetsuo Yasutaka
medRxiv 2022.01.30.22269980; doi: https://doi.org/10.1101/2022.01.30.22269980
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)